speb/financial-data huggingface dataset:
REAX income_statement (annual, 2024-12-31) — Cost Of Revenue: 1149898000.00
REAX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 25939000.00
REAX balance_sheet (annual, 2024-12-31) — Current Assets: 72911000.00
REAX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 24089000.00
REAX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 24089000.00
REAX balance_sheet (annual, 2024-12-31) — Current Liabilities: 54452000.00
REAX cash_flow (annual, 2024-12-31) — Depreciation: 504000.00
REAX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1396000.00
REAX income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1396000.00
REAX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1396000.00
REAX income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1396000.00
REAX income_statement (annual, 2024-12-31) — Depreciation Income Statement: 1396000.00
REAX income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 372000.00
REAX balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
REAX income_statement (annual, 2024-12-31) — Diluted Average Shares: 191172000.00
REAX income_statement (annual, 2024-12-31) — Diluted EPS: -0.14
REAX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -26541000.00
REAX income_statement (annual, 2024-12-31) — EBIT: -26077000.00
REAX income_statement (annual, 2024-12-31) — EBITDA: -24681000.00
REAX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 410000.00
REAX cash_flow (annual, 2024-12-31) — End Cash Position: 47465000.00
REAX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -33140000.00
REAX cash_flow (annual, 2024-12-31) — Free Cash Flow: 47686000.00
REAX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 600000.00
REAX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -600000.00
REAX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 2000.00
REAX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 708000.00
REAX income_statement (annual, 2024-12-31) — General And Administrative Expense: 70842000.00
REAX balance_sheet (annual, 2024-12-31) — Goodwill: 8993000.00
REAX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 11568000.00
REAX balance_sheet (annual, 2024-12-31) — Gross PPE: 3079000.00
REAX income_statement (annual, 2024-12-31) — Gross Profit: 114741000.00
REAX income_statement (annual, 2024-12-31) — Interest Expense: 376000.00
REAX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 376000.00
REAX balance_sheet (annual, 2024-12-31) — Invested Capital: 32146000.00
REAX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 3809000.00
REAX balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
REAX balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
REAX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3079000.00
REAX balance_sheet (annual, 2024-12-31) — Minority Interest: -3000.00
REAX income_statement (annual, 2024-12-31) — Minority Interests: -88000.00
REAX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -36283000.00
REAX income_statement (annual, 2024-12-31) — Net Income: -26541000.00
REAX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -26541000.00
REAX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -26453000.00
REAX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -26541000.00
REAX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -26541000.00
REAX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -26453000.00
REAX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -26453000.00
REAX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
REAX income_statement (annual, 2024-12-31) — Net Interest Income: -1123000.00
REAX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 4854000.00
REAX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1123000.00
REAX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -3132000.00
REAX balance_sheet (annual, 2024-12-31) — Net PPE: 2116000.00
REAX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1045000.00
REAX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 20578000.00
REAX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 0.00
REAX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
REAX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
REAX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
REAX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
REAX income_statement (annual, 2024-12-31) — Normalized EBITDA: -14831000.00
REAX income_statement (annual, 2024-12-31) — Normalized Income: -16691000.00
REAX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 48731000.00
REAX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 600000.00
REAX income_statement (annual, 2024-12-31) — Operating Income: -15976000.00
REAX income_statement (annual, 2024-12-31) — Operating Revenue: 1264639000.00
REAX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 202499045.00
REAX balance_sheet (annual, 2024-12-31) — Other Current Assets: 1762000.00
REAX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1762000.00
REAX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 708000.00
REAX income_statement (annual, 2024-12-31) — Other Gand A: 23283000.00
REAX income_statement (annual, 2024-12-31) — Other Income Expense: -9354000.00
REAX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2575000.00
REAX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 376000.00
REAX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 496000.00
REAX balance_sheet (annual, 2024-12-31) — Other Payable: 3050000.00
REAX balance_sheet (annual, 2024-12-31) — Other Receivables: 117000.00
REAX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 9449000.00
REAX income_statement (annual, 2024-12-31) — Other Special Charges: 9250000.00
REAX income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
REAX balance_sheet (annual, 2024-12-31) — Payables: 4424000.00
REAX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 30363000.00
REAX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1645000.00
REAX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1645000.00
REAX income_statement (annual, 2024-12-31) — Pretax Income: -26453000.00
REAX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 6275000.00
REAX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
REAX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1692000.00
REAX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1045000.00
REAX balance_sheet (annual, 2024-12-31) — Receivables: 14235000.00
REAX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1149898000.00
REAX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1396000.00
REAX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -36283000.00
REAX income_statement (annual, 2024-12-31) — Research And Development: 12156000.00
REAX balance_sheet (annual, 2024-12-31) — Restricted Cash: 24089000.00
REAX balance_sheet (annual, 2024-12-31) — Retained Earnings: -104746000.00
REAX income_statement (annual, 2024-12-31) — Salaries And Wages: 47559000.00
REAX cash_flow (annual, 2024-12-31) — Sale Of Investment: 6546000.00
REAX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 46323000.00
REAX income_statement (annual, 2024-12-31) — Selling General And Administration: 117165000.00
REAX balance_sheet (annual, 2024-12-31) — Share Issued: 202941045.00
REAX income_statement (annual, 2024-12-31) — Special Income Charges: -9250000.00
REAX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 52916000.00
REAX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 32146000.00
REAX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 20578000.00
REAX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
REAX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
REAX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
REAX balance_sheet (annual, 2024-12-31) — Total Assets: 86595000.00
REAX balance_sheet (annual, 2024-12-31) — Total Capitalization: 32146000.00
REAX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 32143000.00
REAX income_statement (annual, 2024-12-31) — Total Expenses: 1280615000.00
REAX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 54452000.00
REAX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 13684000.00
REAX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
REAX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -25226000.00
REAX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 747000.00
REAX income_statement (quarterly, 2024-12-31) — Total Other Finance Cost: 191000.00
REAX income_statement (annual, 2024-12-31) — Total Unusual Items: -9850000.00
REAX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9850000.00
REAX balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 442000.00
REAX balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 442000.00
REAX balance_sheet (annual, 2024-12-31) — Treasury Stock: 2455000.00
REAX balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 2455000.00
REAX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
REAX balance_sheet (annual, 2024-12-31) — Working Capital: 18459000.00
REAX income_statement (quarterly, 2025-03-31) — +Operating Expense: 39145000.00
REAX income_statement (quarterly, 2025-03-31) — +Total Revenue: 353981000.00
REAX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 927000.00
REAX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 16789000.00
REAX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1119000.00
REAX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 142457000.00
REAX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
REAX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 204382000.00
REAX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.02
REAX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 47465000.00
REAX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -285000.00
REAX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 0.00
REAX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 24706000.00
REAX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35260000.00
REAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -7101000.00
REAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1378000.00
REAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 15950000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -447000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 7633000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 175000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 6170000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Payable: -320000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 7313000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 112000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -5524000.00
REAX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 8134000.00
REAX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2555000.00
REAX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 7471000.00
REAX balance_sheet (quarterly, 2025-03-31) — Common Stock: 0.00
REAX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 32752000.00
REAX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -6122000.00
REAX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 320045000.00
REAX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 33572000.00
REAX balance_sheet (quarterly, 2025-03-31) — Current Assets: 83895000.00
REAX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 30259000.00
REAX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 30259000.00
REAX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 67935000.00
REAX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 379000.00
REAX income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 379000.00
REAX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 379000.00
REAX income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 379000.00
REAX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 204382000.00
REAX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.02
REAX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4967000.00
REAX income_statement (quarterly, 2025-03-31) — EBIT: -5087000.00
REAX income_statement (quarterly, 2025-03-31) — EBITDA: -4708000.00
REAX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 29000.00
REAX cash_flow (quarterly, 2025-03-31) — End Cash Position: 54965000.00
REAX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7101000.00
REAX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 15665000.00
REAX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -5000.00
REAX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 599000.00
REAX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 20682000.00
REAX balance_sheet (quarterly, 2025-03-31) — Goodwill: 8993000.00
REAX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 11345000.00
REAX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3364000.00
REAX income_statement (quarterly, 2025-03-31) — Gross Profit: 33936000.00
REAX income_statement (quarterly, 2025-03-31) — Interest Expense: 34000.00
REAX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 34000.00
REAX income_statement (quarterly, 2025-03-31) — Interest Income: 149000.00
REAX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 149000.00
REAX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 32752000.00
REAX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1378000.00
REAX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3364000.00
REAX balance_sheet (quarterly, 2025-03-31) — Minority Interest: -233000.00
REAX income_statement (quarterly, 2025-03-31) — Minority Interests: 154000.00
REAX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -6122000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income: -4967000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4967000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5121000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -4967000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -4967000.00
REAX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5121000.00
REAX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5121000.00
REAX income_statement (quarterly, 2025-03-31) — Net Interest Income: -34000.00
REAX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -1093000.00
REAX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -34000.00
REAX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1289000.00
REAX balance_sheet (quarterly, 2025-03-31) — Net PPE: 2245000.00
REAX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -285000.00
REAX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 21407000.00
REAX balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 2969000.00
REAX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4708000.00
REAX income_statement (quarterly, 2025-03-31) — Normalized Income: -4967000.00
REAX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 15950000.00
REAX income_statement (quarterly, 2025-03-31) — Operating Income: -5209000.00
REAX income_statement (quarterly, 2025-03-31) — Operating Revenue: 353981000.00
REAX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 205158424.00
REAX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 599000.00
REAX income_statement (quarterly, 2025-03-31) — Other Gand A: 6130000.00
REAX income_statement (quarterly, 2025-03-31) — Other Income Expense: 122000.00
REAX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2352000.00
REAX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -149000.00
REAX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 122000.00
REAX balance_sheet (quarterly, 2025-03-31) — Other Payable: 3177000.00
REAX balance_sheet (quarterly, 2025-03-31) — Other Receivables: 54000.00
REAX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 10554000.00
REAX balance_sheet (quarterly, 2025-03-31) — Payables: 4104000.00
REAX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 37676000.00
REAX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1533000.00
REAX income_statement (quarterly, 2025-03-31) — Pretax Income: -5121000.00
REAX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 310000.00
REAX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1350000.00
REAX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -285000.00
REAX balance_sheet (quarterly, 2025-03-31) — Receivables: 16843000.00
REAX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 320045000.00
REAX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 379000.00
REAX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -6122000.00
REAX income_statement (quarterly, 2025-03-31) — Research And Development: 3932000.00
REAX balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 30259000.00
REAX income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
REAX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -109713000.00
REAX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 14552000.00
REAX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 257000.00
REAX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 14152000.00
REAX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 34834000.00
REAX balance_sheet (quarterly, 2025-03-31) — Share Issued: 205285066.00
REAX income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
REAX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12707000.00
REAX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 32752000.00
REAX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 21407000.00
REAX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
REAX income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
REAX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Assets: 100454000.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 32752000.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 32519000.00
REAX income_statement (quarterly, 2025-03-31) — Total Expenses: 359190000.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 67935000.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 16559000.00
REAX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
REAX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5209000.00
REAX income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 178000.00
REAX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
REAX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
REAX balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 126642.00
REAX balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 591000.00
REAX balance_sheet (quarterly, 2025-03-31) — Working Capital: 15960000.00
REAX income_statement (quarterly, 2025-06-30) — +Operating Expense: 46178000.00
REAX income_statement (quarterly, 2025-06-30) — +Total Revenue: 540747000.00
REAX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1251000.00
REAX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 26821000.00
REAX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1295000.00
REAX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 158827000.00
REAX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 214787000.00
REAX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.01
REAX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 54965000.00
REAX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -255000.00
REAX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
REAX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 49614000.00
REAX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 54772000.00
REAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2878000.00
REAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 2882000.00
REAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 41018000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 324000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 14496000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 16043000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Payable: 1990000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 16486000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -39000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -11277000.00
REAX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 21213000.00
REAX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -10031000.00
REAX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 41022000.00
REAX balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
REAX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 49187000.00
REAX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2708000.00
REAX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 492886000.00
REAX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 48068000.00
REAX balance_sheet (quarterly, 2025-06-30) — Current Assets: 129590000.00
REAX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 46302000.00
REAX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 46302000.00
REAX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 100464000.00
REAX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 398000.00
REAX income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 398000.00
REAX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 398000.00
REAX income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 398000.00
REAX income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 398000.00
REAX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 233366000.00
REAX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.01
REAX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1512000.00
REAX income_statement (quarterly, 2025-06-30) — EBIT: 1849000.00
REAX income_statement (quarterly, 2025-06-30) — EBITDA: 2247000.00
REAX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -71000.00
REAX cash_flow (quarterly, 2025-06-30) — End Cash Position: 95916000.00
REAX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2878000.00
REAX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 40763000.00
REAX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 582000.00
REAX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 22436000.00
REAX balance_sheet (quarterly, 2025-06-30) — Goodwill: 8993000.00
REAX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 11123000.00
REAX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3619000.00
REAX income_statement (quarterly, 2025-06-30) — Gross Profit: 47861000.00
REAX income_statement (quarterly, 2025-06-30) — Interest Expense: 300000.00
REAX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 300000.00
REAX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 49187000.00
REAX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 2882000.00
REAX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2250000.00
REAX balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 2250000.00
REAX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3619000.00
REAX balance_sheet (quarterly, 2025-06-30) — Minority Interest: -218000.00
REAX income_statement (quarterly, 2025-06-30) — Minority Interests: -38000.00
REAX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2708000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income: 1512000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1512000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1549000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1512000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1512000.00
REAX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1550000.00
REAX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1549000.00
REAX income_statement (quarterly, 2025-06-30) — Net Interest Income: -300000.00
REAX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 3137000.00
REAX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -300000.00
REAX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -521000.00
REAX balance_sheet (quarterly, 2025-06-30) — Net PPE: 2324000.00
REAX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -255000.00
REAX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 38064000.00
REAX balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 4146000.00
REAX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 2247000.00
REAX income_statement (quarterly, 2025-06-30) — Normalized Income: 1512000.00
REAX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 41018000.00
REAX income_statement (quarterly, 2025-06-30) — Operating Income: 1683000.00
REAX income_statement (quarterly, 2025-06-30) — Operating Revenue: 540747000.00
REAX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 208121000.00
REAX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 582000.00
REAX income_statement (quarterly, 2025-06-30) — Other Gand A: 7030000.00
REAX income_statement (quarterly, 2025-06-30) — Other Income Expense: 166000.00
REAX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2130000.00
REAX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 62000.00
REAX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 166000.00
REAX balance_sheet (quarterly, 2025-06-30) — Other Payable: 4843000.00
REAX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 123000.00
REAX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 5158000.00
REAX balance_sheet (quarterly, 2025-06-30) — Payables: 6094000.00
REAX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 54162000.00
REAX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1572000.00
REAX income_statement (quarterly, 2025-06-30) — Pretax Income: 1549000.00
REAX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 351000.00
REAX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -2359000.00
REAX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -255000.00
REAX balance_sheet (quarterly, 2025-06-30) — Receivables: 26944000.00
REAX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 492886000.00
REAX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 398000.00
REAX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -2708000.00
REAX income_statement (quarterly, 2025-06-30) — Research And Development: 3993000.00
REAX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 46302000.00
REAX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -108201000.00
REAX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 15406000.00
REAX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 5496000.00
REAX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 19351000.00
REAX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 41787000.00
REAX balance_sheet (quarterly, 2025-06-30) — Share Issued: 208613000.00
REAX income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
REAX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 17795000.00
REAX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 49187000.00
REAX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 38064000.00
REAX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
REAX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
REAX balance_sheet (quarterly, 2025-06-30) — Total Assets: 149433000.00
REAX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 49187000.00
REAX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 48969000.00
REAX income_statement (quarterly, 2025-06-30) — Total Expenses: 539064000.00
REAX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 100464000.00
REAX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 19843000.00
REAX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
REAX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 1684000.00
REAX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
REAX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
REAX balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 492000.00
REAX balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 2021000.00
REAX balance_sheet (quarterly, 2025-06-30) — Working Capital: 29126000.00
REAX income_statement (quarterly, 2025-09-30) — +Operating Expense: 45330000.00
REAX income_statement (quarterly, 2025-09-30) — +Total Revenue: 568549000.00
REAX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1078000.00
REAX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 27861000.00
REAX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1500000.00
REAX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 161896000.00
REAX cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 362000.00
REAX cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 362000.00
REAX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 218996000.00
REAX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
REAX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 95916000.00
REAX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3145000.00
REAX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
REAX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 36427000.00
REAX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 55779000.00
REAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -14818000.00
REAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -17470000.00
REAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 8809000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -173000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -413000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -1278000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -10357000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Payable: 1928000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1515000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1276000.00
REAX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -11396000.00
REAX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1040000.00
REAX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -23479000.00
REAX balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
REAX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 53640000.00
REAX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -15469000.00
REAX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 523692000.00
REAX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 47655000.00
REAX balance_sheet (quarterly, 2025-09-30) — Current Assets: 124710000.00
REAX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 35945000.00
REAX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 35945000.00
REAX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 91622000.00
REAX cash_flow (quarterly, 2025-09-30) — Depreciation: 205000.00
REAX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 567000.00
REAX income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 567000.00
REAX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 567000.00
REAX income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 567000.00
REAX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 218996000.00
REAX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
REAX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -447000.00
REAX income_statement (quarterly, 2025-09-30) — EBIT: -108000.00
REAX income_statement (quarterly, 2025-09-30) — EBITDA: 459000.00
REAX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -65000.00
REAX cash_flow (quarterly, 2025-09-30) — End Cash Position: 72372000.00
REAX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -14818000.00
REAX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 5664000.00
REAX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 392000.00
REAX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 23447000.00
REAX balance_sheet (quarterly, 2025-09-30) — Goodwill: 8993000.00
REAX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 13511000.00
REAX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4014000.00
REAX income_statement (quarterly, 2025-09-30) — Gross Profit: 44857000.00
REAX income_statement (quarterly, 2025-09-30) — Interest Expense: 83000.00
REAX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 83000.00
REAX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 53640000.00
REAX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -17470000.00
REAX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2250000.00
REAX balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 2250000.00
REAX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 4014000.00
REAX balance_sheet (quarterly, 2025-09-30) — Minority Interest: -47000.00
REAX income_statement (quarterly, 2025-09-30) — Minority Interests: -167000.00
REAX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -15469000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income: -447000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -447000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -280000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -447000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -447000.00
REAX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -280000.00
REAX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -280000.00
REAX cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -2750000.00
REAX income_statement (quarterly, 2025-09-30) — Net Interest Income: -83000.00
REAX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -14325000.00
REAX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -83000.00
REAX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -259000.00
REAX balance_sheet (quarterly, 2025-09-30) — Net PPE: 2514000.00
REAX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -395000.00
REAX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 40129000.00
REAX balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 2230000.00
REAX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 459000.00
REAX income_statement (quarterly, 2025-09-30) — Normalized Income: -447000.00
REAX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 8809000.00
REAX income_statement (quarterly, 2025-09-30) — Operating Income: -473000.00
REAX income_statement (quarterly, 2025-09-30) — Operating Revenue: 568549000.00
REAX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 210911000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2901000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 392000.00
REAX income_statement (quarterly, 2025-09-30) — Other Gand A: 6224000.00
REAX income_statement (quarterly, 2025-09-30) — Other Income Expense: 365000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 4518000.00
REAX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 6000.00
REAX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 365000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Payable: 6944000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2224000.00
REAX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 19352000.00
REAX balance_sheet (quarterly, 2025-09-30) — Payables: 8022000.00
REAX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 55677000.00
REAX income_statement (quarterly, 2025-09-30) — Pretax Income: -191000.00
REAX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 910000.00
REAX cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -2750000.00
REAX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -14325000.00
REAX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -395000.00
REAX balance_sheet (quarterly, 2025-09-30) — Receivables: 30085000.00
REAX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 523692000.00
REAX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 567000.00
REAX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -15469000.00
REAX income_statement (quarterly, 2025-09-30) — Research And Development: 4712000.00
REAX balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 35945000.00
REAX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -108648000.00
REAX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 17223000.00
REAX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
REAX income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 16604000.00
REAX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 40051000.00
REAX balance_sheet (quarterly, 2025-09-30) — Share Issued: 210911000.00
REAX income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
REAX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 19912000.00
REAX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 53640000.00
REAX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 40129000.00
REAX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
REAX income_statement (quarterly, 2025-09-30) — Tax Provision: 89000.00
REAX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
REAX balance_sheet (quarterly, 2025-09-30) — Total Assets: 145215000.00
REAX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 53640000.00
REAX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 53593000.00
REAX income_statement (quarterly, 2025-09-30) — Total Expenses: 569022000.00
REAX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 91622000.00
REAX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 20505000.00
REAX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
REAX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -473000.00
REAX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
REAX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
REAX balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 0.00
REAX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 0.00
REAX balance_sheet (quarterly, 2025-09-30) — Working Capital: 33088000.00
REAX income_statement (annual, 2025-12-31) — +Operating Expense: 174185000.00
REAX income_statement (quarterly, 2025-12-31) — +Operating Expense: 43533000.00
REAX income_statement (annual, 2025-12-31) — +Total Revenue: 1968416000.00
REAX income_statement (quarterly, 2025-12-31) — +Total Revenue: 505139000.00
REAX balance_sheet (annual, 2025-12-31) — Accounts Payable: 1161000.00
REAX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1161000.00
REAX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 20170000.00
REAX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 20170000.00
REAX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1724000.00
REAX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1724000.00
REAX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 164208000.00
REAX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 164208000.00
REAX cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1168000.00
REAX cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 361000.00
REAX cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1168000.00
REAX cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 361000.00
REAX income_statement (annual, 2025-12-31) — Basic Average Shares: 219873000.00
REAX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 221311000.00
REAX income_statement (annual, 2025-12-31) — Basic EPS: -0.04
REAX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.02
REAX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 47465000.00
REAX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 72372000.00
REAX cash_flow (annual, 2025-12-31) — Capital Expenditure: -3850000.00
REAX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -165000.00
REAX balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
REAX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
REAX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 33213000.00
REAX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 33213000.00
REAX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 49944000.00
REAX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 49944000.00
REAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -40248000.00
REAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -15451000.00
REAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -13594000.00
REAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2372000.00
REAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 65926000.00
REAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 149000.00
REAX cash_flow (annual, 2025-12-31) — Change In Account Payable: -213000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 83000.00
REAX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 12266000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -9450000.00
REAX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -1319000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -180000.00
REAX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 2249000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -9607000.00
REAX cash_flow (annual, 2025-12-31) — Change In Payable: 6299000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Payable: 2701000.00
REAX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 18565000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -6749000.00
REAX cash_flow (annual, 2025-12-31) — Change In Receivables: -14477000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Receivables: 3603000.00
REAX cash_flow (annual, 2025-12-31) — Change In Working Capital: 5018000.00
REAX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -12933000.00
REAX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5935000.00
REAX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 7691000.00
REAX cash_flow (annual, 2025-12-31) — Changes In Cash: 12084000.00
REAX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -12930000.00
REAX balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
REAX balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
REAX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 51675000.00
REAX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 51675000.00
REAX cash_flow (annual, 2025-12-31) — Common Stock Payments: -39363000.00
REAX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -15064000.00